Ida Ayu Sri Wijayanti
Research Subjects
Ida Ayu Sri Wijayanti has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Kumara Tini
Department of Neurology, Faculty of Medicine, Udayana University/ Udayana Hospital, Bali, Indonesia
5 shared publications - Ni Made Susilawathi
Department of Neurology, Faculty of Medicine, Udayana University, Prof. Dr. I.G.N.G. Ngoerah General Hospital, Bali 80113, Indonesia
4 shared publications - Dewa Putu Gde Purwa Samatra
Department of Neurology, Faculty of Medicine, Universitas Udayana, Universitas Udayana Hospital, Badung, Indonesia
2 shared publications - Dpg Purwa Samatra
Department of Neurology, Udayana University, Udayana University Hospital, Bali, Indonesia
2 shared publications - Made Oka Adnyana
Department of Neurology, Faculty of Medicine, Udayana University/ Udayana Hospital, Bali, Indonesia / Prof.Dr.dr.IGNG Ngoerah/Sanglah General Hospital, Bali, Indonesia
2 shared publications - Prysta Aderlia Sitanggang
Program Studi Sarjana Kedokteran, Fakultas Kedokteran, Universitas Cenderawasih, Indonesia
2 shared publications
Latest Publications
- Open Access
- 31 October 2023
- Published by Universitas Sebelas Maret in Medical Science and Hospital Management Journal
- Vol. 1 (2) , 1-10
Optimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana
Optimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana
- 31 October 2023
- Published by Universitas Sebelas Maret in Medical Science and Hospital Management Journal
- Vol. 1 (2) , 1-10
Open AccessOptimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana
Optimalisasi Kualitas Pendidikan Klinik melalui Evaluasi Sistem E-Learning pada Pendidikan Dokter Muda Fakultas Kedokteran Universitas Udayana
- Open Access
- 6 April 2023
- Published by Universa Medicina in Universa Medicina
- Vol. 42 (1) , 52-60
Headache in healthcare workers related to personal protective equipment use in COVID-19 referral hospital
Background Studies show that wearing personal protective equipment (PPE) for long periods of time can lead to discomfort such as headaches, which could affect the performance of healthcare workers. The aim of this study was to determine the prevalence and risk factors of headaches related to PPE in healthcare workers at a COVID-19 referral hospital. Methods A cross-sectional study was conducted involving 174 healthcare workers in a COVID-19 referral hospital in Bali. We conducted interviews using a questionnaire that consisted of three main parts: characteristics of the subjects, PPE usage, and PPE-associated headaches. A multiple logistic regression was used to analyze the data. Results The analysis results showed that the PPE-associated headaches had a prevalence of 63.8% and were gradual in onset, pressure-like in quality (46%), and mild in intensity (80.1%). PPE level III-associated headache was the most common type. The majority of the participants had headaches up to 6 hours after using the protective gear, but improving within 15-30 minutes of removal and/or after pharmacotherapy. A Chi-squared analysis showed a statistically significant association between duration of PPE use, working units, and PPE levels (pConclusion The frequency of PPE-associated headache was high and the PPE level was a risk factor of headache among healthcare workers. Better strategies are needed to reduce the duration of PPE exposure so that the work performance and quality of life of healthcare workers are not significantly affected.
- 6 April 2023
- Published by Universa Medicina in Universa Medicina
- Vol. 42 (1) , 52-60
Open AccessHeadache in healthcare workers related to personal protective equipment use in COVID-19 referral hospital
Background Studies show that wearing personal protective equipment (PPE) for long periods of time can lead to discomfort such as headaches, which could affect the performance of healthcare workers. The aim of this study was to determine the prevalence and risk factors of headaches related to PPE in healthcare workers at a COVID-19 referral hospital. Methods A cross-sectional study was conducted involving 174 healthcare workers in a COVID-19 referral hospital in Bali. We conducted interviews using a questionnaire that consisted of three main parts: characteristics of the subjects, PPE usage, and PPE-associated headaches. A multiple logistic regression was used to analyze the data. Results The analysis results showed that the PPE-associated headaches had a prevalence of 63.8% and were gradual in onset, pressure-like in quality (46%), and mild in intensity (80.1%). PPE level III-associated headache was the most common type. The majority of the participants had headaches up to 6 hours after using the protective gear, but improving within 15-30 minutes of removal and/or after pharmacotherapy. A Chi-squared analysis showed a statistically significant association between duration of PPE use, working units, and PPE levels (pConclusion The frequency of PPE-associated headache was high and the PPE level was a risk factor of headache among healthcare workers. Better strategies are needed to reduce the duration of PPE exposure so that the work performance and quality of life of healthcare workers are not significantly affected.
- Open Access
- 5 November 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-8
Migraine as a risk factor for ischemic stroke: a systematic review and meta-analysis of cohort studies
Background: Migraine and stroke are neurovascular diseases that have become a public health problem and a relatively high economic burden. The relationship between migraine and stroke has been described in the literature for a long time. Several studies reveal that migraine can be a risk factor for stroke. Methods: We systematically searched PubMed using the PRISMA method and keywords according to MeSH terms to prepare this systematic review. We included published articles discussing migraine as a risk factor for ischemic stroke with a cohort study design and English article and listed the statistical value of the study. Results: In our meta-analysis, we found that migraine significantly increases the incidence of ischemic stroke. There were 12 studies included in this systematic review, and a meta-analysis was performed. The results showed a significant association between migraine and ischemic stroke (HR 1.205, 95% CI 1.151–1.262 p = 0.000), migraine with aura and ischemic stroke (HR 1.442, 95% CI 1.241–1.675 p = 0.000), and migraine without aura and ischemic stroke (HR 1.126, 95% CI 1.048–1.211 p = 0.001). The exact mechanism of stroke caused by migraine is still unclear, although, in some theories, several mechanisms have been described that are thought to be the cause of stroke. Several important points of the cause of stroke in migraine are hemodynamic changes, endothelial dysfunction, cervical artery dissection, vascular reactivity, hypercoagulability, and abortive migraine drugs. Conclusions: Both migraine with aura and without aura are risk factors for ischemic stroke. Several mechanisms that may cause ischemic stroke in migraine have been described, of which CSD-induced endothelial dysfunction is the primary pathophysiology of ischemic stroke in migraine.
- 5 November 2022
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 58 (1) , 1-8
Open AccessMigraine as a risk factor for ischemic stroke: a systematic review and meta-analysis of cohort studies
Background: Migraine and stroke are neurovascular diseases that have become a public health problem and a relatively high economic burden. The relationship between migraine and stroke has been described in the literature for a long time. Several studies reveal that migraine can be a risk factor for stroke. Methods: We systematically searched PubMed using the PRISMA method and keywords according to MeSH terms to prepare this systematic review. We included published articles discussing migraine as a risk factor for ischemic stroke with a cohort study design and English article and listed the statistical value of the study. Results: In our meta-analysis, we found that migraine significantly increases the incidence of ischemic stroke. There were 12 studies included in this systematic review, and a meta-analysis was performed. The results showed a significant association between migraine and ischemic stroke (HR 1.205, 95% CI 1.151–1.262 p = 0.000), migraine with aura and ischemic stroke (HR 1.442, 95% CI 1.241–1.675 p = 0.000), and migraine without aura and ischemic stroke (HR 1.126, 95% CI 1.048–1.211 p = 0.001). The exact mechanism of stroke caused by migraine is still unclear, although, in some theories, several mechanisms have been described that are thought to be the cause of stroke. Several important points of the cause of stroke in migraine are hemodynamic changes, endothelial dysfunction, cervical artery dissection, vascular reactivity, hypercoagulability, and abortive migraine drugs. Conclusions: Both migraine with aura and without aura are risk factors for ischemic stroke. Several mechanisms that may cause ischemic stroke in migraine have been described, of which CSD-induced endothelial dysfunction is the primary pathophysiology of ischemic stroke in migraine.
- Open Access
- 29 June 2021
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 57 (1) , 1-7
Case reports of cerebral sinus venous thrombosis in COVID-19 patients
Background: Coronavirus disease 2019 (COVID-19) pandemic has started in December 2019 and still ongoing. The disease has been expanding rapidly with a high variety of phenotypes from asymptomatic, mild respiratory tract infection, multiple organ system dysfunction, and death. Neurological manifestations also appear in patients with COVID-19, such as headache, seizures, a decrease of consciousness, and paralysis. The hypercoagulable state in patients with COVID-19 is associated with the thromboembolic incident including ischemic strokes, venous thromboembolism, pulmonary artery embolism, and many further. Cerebral sinus venous thrombosis (CSVT) is a rare neurovascular emergency that is often found in critically ill patients. We report two cases of CSVT with different onsets, neurologic manifestations, and prognoses. Case presentation: Two cases of cerebral sinus venous thrombosis in COVID-19 patients were reported, following respiratory, hematology, and coagulation disarrangements, which was triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The first patient, which was presented with a seizure, had hypertension and diabetes mellitus as comorbidities. The latter case had no comorbidity but showed more severe presentations of COVID-19 such as brain and lung thrombosis, although already had several days of intravenous anticoagulant administrations. These two cases also have a different course of disease and outcomes, which were interesting topics to study. Conclusions: CSVT is one of the neurological complications of the COVID-19 when the brainstem venous drainage is involved. Despite successful alteration to the negative result of SARS-CoV-2 through the rt-PCR test, thrombogenesis and coagulation cascade continuing. Therefore, a high level of neutrophil to lymphocyte ratio (NLR), D-dimer, fibrinogen, and C-reactive protein (CRP) are paramount indicators of poor prognosis.
- 29 June 2021
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 57 (1) , 1-7
Open AccessCase reports of cerebral sinus venous thrombosis in COVID-19 patients
Background: Coronavirus disease 2019 (COVID-19) pandemic has started in December 2019 and still ongoing. The disease has been expanding rapidly with a high variety of phenotypes from asymptomatic, mild respiratory tract infection, multiple organ system dysfunction, and death. Neurological manifestations also appear in patients with COVID-19, such as headache, seizures, a decrease of consciousness, and paralysis. The hypercoagulable state in patients with COVID-19 is associated with the thromboembolic incident including ischemic strokes, venous thromboembolism, pulmonary artery embolism, and many further. Cerebral sinus venous thrombosis (CSVT) is a rare neurovascular emergency that is often found in critically ill patients. We report two cases of CSVT with different onsets, neurologic manifestations, and prognoses. Case presentation: Two cases of cerebral sinus venous thrombosis in COVID-19 patients were reported, following respiratory, hematology, and coagulation disarrangements, which was triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The first patient, which was presented with a seizure, had hypertension and diabetes mellitus as comorbidities. The latter case had no comorbidity but showed more severe presentations of COVID-19 such as brain and lung thrombosis, although already had several days of intravenous anticoagulant administrations. These two cases also have a different course of disease and outcomes, which were interesting topics to study. Conclusions: CSVT is one of the neurological complications of the COVID-19 when the brainstem venous drainage is involved. Despite successful alteration to the negative result of SARS-CoV-2 through the rt-PCR test, thrombogenesis and coagulation cascade continuing. Therefore, a high level of neutrophil to lymphocyte ratio (NLR), D-dimer, fibrinogen, and C-reactive protein (CRP) are paramount indicators of poor prognosis.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (2) , 155-163
Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
Rahmawati PL, et al. J Clin Neurol. 2021 Apr;17(2):155-163. https://doi.org/10.3988/jcn.2021.17.2.155
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (2) , 155-163
Open AccessPathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2
Rahmawati PL, et al. J Clin Neurol. 2021 Apr;17(2):155-163. https://doi.org/10.3988/jcn.2021.17.2.155
- Open Access
- 25 November 2020
- Published by Callosum Neurology in Callosum Neurology
- Vol. 3 (3) , 106-117
TATA LAKSANA PEMERIKSAAN NEUROLOGIS VIRTUAL DI ERA PANDEMI CORONA VIRUS DISEASE 2019
Latar Belakang: Pandemi Corona Virus Disease 2019 (COVID-19) dengan penularannya yang sangat cepat di seluruh dunia berdampak terhadap perubahan pelayanan kesehatan di bidang neurologi sebagai upaya mendukung program pengendalian penyakit ini. Tujuan: Merumuskan rekomendasi panduan pemeriksaan neurologis untuk pelayanan teleneurologi. Diskusi: Penyesuaian dalam pelaksanaan pelayanan neurologi perlu segera dilakukan dengan mengadopsi metode pelayanan dengan telemedicine terutama dalam tata cara pemeriksaan pasien dengan pembatasan fisik dan sosial sebagai salah satu langkah pencegahan infeksi SARS-CoV-2. Simpulan: Layanan teleneurologi perlu dikembangkan dalam pelayanan neurologi termasuk pengembangan prosedur pemeriksaan neurologis secara virtual.
- 25 November 2020
- Published by Callosum Neurology in Callosum Neurology
- Vol. 3 (3) , 106-117
Open AccessTATA LAKSANA PEMERIKSAAN NEUROLOGIS VIRTUAL DI ERA PANDEMI CORONA VIRUS DISEASE 2019
Latar Belakang: Pandemi Corona Virus Disease 2019 (COVID-19) dengan penularannya yang sangat cepat di seluruh dunia berdampak terhadap perubahan pelayanan kesehatan di bidang neurologi sebagai upaya mendukung program pengendalian penyakit ini. Tujuan: Merumuskan rekomendasi panduan pemeriksaan neurologis untuk pelayanan teleneurologi. Diskusi: Penyesuaian dalam pelaksanaan pelayanan neurologi perlu segera dilakukan dengan mengadopsi metode pelayanan dengan telemedicine terutama dalam tata cara pemeriksaan pasien dengan pembatasan fisik dan sosial sebagai salah satu langkah pencegahan infeksi SARS-CoV-2. Simpulan: Layanan teleneurologi perlu dikembangkan dalam pelayanan neurologi termasuk pengembangan prosedur pemeriksaan neurologis secara virtual.
- Open Access
- 6 November 2020
- Published by Springer Nature in Research Square
Case Reports of Cerebral Sinus Venous Thrombosis in COVID-19 Patients
Background: The outbreak of Coronavirus disease 2019 (COVID-19) has started in China since December 2019 and expanding worldwide rapidly with cases of respiratory tract infection and multiple system involvement. Neurological manifestations are not exempted following the reports from various sources about Ischemic and haemorrhagic stroke related to COVID-19, but the reports about cerebral sinus venous thrombosis (CSVT) are still rare.Case presentation: We would like to report two cases of cerebral sinus venous thrombosis in COVID-19 patients following the respiratory manifestations with profound haematological and coagulation disarrangement triggered by COVID-19 and these are assumed as underlying mechanism. These two cases also have different course of disease and outcome which are interesting.Conclusions: CSVT is one of neurological complication and COVID -19 manifestation that can have grave prognosis, if this involves the brainstem venous drainage. Thrombogenesis and coagulation cascades are prolonged despite successful alteration to negative result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) reverse transcription polymerase chain reaction (rt-PCR) test. Therefore, monitoring neutrophil to lymphocyte ration (NLR), D-dimer level, fibrinogen and C-reactive protein (CRP) is paramount as well as indicators of poor prognosis.
- 6 November 2020
- Published by Springer Nature in Research Square
Open AccessCase Reports of Cerebral Sinus Venous Thrombosis in COVID-19 Patients
Background: The outbreak of Coronavirus disease 2019 (COVID-19) has started in China since December 2019 and expanding worldwide rapidly with cases of respiratory tract infection and multiple system involvement. Neurological manifestations are not exempted following the reports from various sources about Ischemic and haemorrhagic stroke related to COVID-19, but the reports about cerebral sinus venous thrombosis (CSVT) are still rare.Case presentation: We would like to report two cases of cerebral sinus venous thrombosis in COVID-19 patients following the respiratory manifestations with profound haematological and coagulation disarrangement triggered by COVID-19 and these are assumed as underlying mechanism. These two cases also have different course of disease and outcome which are interesting.Conclusions: CSVT is one of neurological complication and COVID -19 manifestation that can have grave prognosis, if this involves the brainstem venous drainage. Thrombogenesis and coagulation cascades are prolonged despite successful alteration to negative result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) reverse transcription polymerase chain reaction (rt-PCR) test. Therefore, monitoring neutrophil to lymphocyte ration (NLR), D-dimer level, fibrinogen and C-reactive protein (CRP) is paramount as well as indicators of poor prognosis.